Wednesday, July 8, 2026
🇺🇸 FDA

pharma · Diabetes Mellitus · Hemophilia A

Takeda

Takeda clinical programs — 1179 development programs from ClinicalTrials.gov with phase, modality, indication, and trial identifiers.

Website Investor relations
Cambridge, USA HQ
1993 Founded
1,617 Employees
NMPA registrant Type
Company details
Status
Public
HQ
Cambridge, USA
Founded
1993
Employees
1,617
Programs
1179
Drugs
359
Patents
1436
Official website ↗ All projects Drug pipeline Patents News & analysis

Recent coverage

View all news & analysis →
Intelligence · Clinical Programs

Takeda projects

1,179 ClinicalTrials.gov programs sponsored by Takeda.

Takeda has 1,179 clinical development programs indexed from ClinicalTrials.gov, including phase, modality, indication text, and linked NCT identifiers.

All phases Phase III Phase II Phase I NDA / BLA filed Approved programs

1,179 programs

Clinical programs

Page 22 of 25

  1. 220901

    Takeda

    Prothrombin Complex Factor Deficiency

    approved mab completed

    1 trial

  2. AD-4833 15 mg

    Takeda

    Diabetes Mellitus

    approved small molecule completed

    1 trial

  3. ADVATE

    Takeda

    Hemophilia A

    approved mab completed

    1 trial

  4. AO-128

    Takeda

    Impaired Glucose Tolerance (IGT)

    approved small molecule completed

    1 trial

  5. ARALAST Alpha1-Proteinase Inhibitor

    Takeda

    Alpha1-antitrypsin Deficiency

    approved small molecule terminated

    1 trial

  6. ARALAST NP

    Takeda

    Chronic Obstructive Pulmonary Disease

    approved mab terminated

    1 trial

  7. Adalimumab

    Takeda

    Crohn's Disease

    approved small molecule active

    1 trial

  8. Alofisel 5 × 106 cells/mL dispersion for injection.

    Takeda

    Perianal fistulising Crohn´s disease

    approved small molecule active

    1 trial

  9. Alogliptin

    Takeda

    Diabetes Mellitus, Type 2

    approved small molecule completed

    6 trials

  10. Alpha1-Proteinase Inhibitor

    Takeda

    Alpha 1-Antitrypsin Deficiency

    approved mab completed

    1 trial

  11. Alpha1-proteinase inhibitor

    Takeda

    Alpha1-antitrypsin Deficiency

    approved mab completed

    1 trial

  12. Ampicillin

    Takeda

    Surgical Site Infection

    approved small molecule completed

    1 trial

  13. Anagrelide

    Takeda

    Thrombocythemia, Hemorrhagic

    approved small molecule completed

    1 trial

  14. Antihemophilic Factor (Recombinant) - Plasma/Albumin Free Method

    Takeda

    Hemophilia A

    approved mab completed

    4 trials

  15. Azilsartan

    Takeda

    Essential Hypertension Complicated by Type 2 Diabetes Mellitus

    approved small molecule completed

    1 trial

  16. Azilsartan

    Takeda

    Essential Hypertension With Stable Angina and Dyslipidemia

    approved small molecule terminated

    1 trial

  17. Azilsartan Medoxomil

    Takeda

    Essential Hypertension

    approved small molecule completed

    2 trials

  18. BLB-750 Vaccine (Qinghai RG strain)

    Takeda

    Pandemic Influenza Prevention

    approved mab completed

    1 trial

  19. Brentuximab vedotin

    Takeda

    Lymphoma

    approved small molecule active

    2 trials

  20. Brentuximab vedotin

    Takeda

    T-Cell Lymphoma

    approved small molecule completed

    1 trial

  21. C1 inhibitor (human) [C1 INH]

    Takeda

    Hereditary Angioedema

    approved mab completed

    1 trial

  22. CDPATH™

    Takeda

    Crohn's Disease

    approved other active

    1 trial

  23. Caffeine

    Takeda

    Colitis, Ulcerative

    approved small molecule terminated

    1 trial

  24. Calcichew D3

    Takeda

    Calcium and Vitamin D Deficiencies

    approved small molecule completed

    1 trial

  25. Candesartan

    Takeda

    Cerebrovascular Accident

    approved small molecule active

    1 trial

  26. Candesartan and Hydrochlorothiazide

    Takeda

    Obesity

    approved small molecule completed

    1 trial

  27. Candesartan cilexetil and hydrochlorothiazide

    Takeda

    Hypertension

    approved small molecule completed

    1 trial

  28. Cardiovascular drugs strategies

    Takeda

    High Risk Hypertensive Patients

    approved other completed

    1 trial

  29. Ciclesonide

    Takeda

    Allergic Rhinitis

    approved small molecule completed

    1 trial

  30. Colchicine

    Takeda

    Pharmacokinetics

    approved small molecule completed

    1 trial

  31. Colchicine

    Takeda

    Coronary Artery Disease

    approved small molecule completed

    1 trial

  32. Coumarin/troxerutin

    Takeda

    Chronic Venous Insufficiency

    approved small molecule completed

    1 trial

  33. Darvadstrocel

    Takeda

    Crohn's Disease

    approved mab terminated

    3 trials

  34. Dexlansoprazole

    Takeda

    Gastroesophageal Reflux Disease

    approved small molecule completed

    4 trials

  35. Dexlansoprazole 60 MG

    Takeda

    GERD

    approved small molecule completed

    1 trial

  36. Digital Engagement Application (GD App)

    Takeda

    Gaucher Disease

    approved other completed

    1 trial

  37. Double dose of PPI

    Takeda

    Dyspepsia

    approved small molecule completed

    1 trial

  38. Dynepo

    Takeda

    Anemia

    approved small molecule terminated

    1 trial

  39. EC/2013/472

    Takeda

    Prostate or Bladder Cancer

    approved small molecule completed

    1 trial

  40. ELAPRASE

    Takeda

    Mucopolysaccharidosis (MPS)

    approved small molecule terminated

    1 trial

  41. Elaprase

    Takeda

    Hunter Syndrome

    approved mab completed

    1 trial

  42. Elaprase for intravenous (IV) infusion

    Takeda

    Hunter Syndrome

    approved small molecule completed

    1 trial

  43. Febuxostat

    Takeda

    Gout

    approved small molecule completed

    6 trials

  44. Febuxostat

    Takeda

    Coronary Artery Disease

    approved small molecule completed

    1 trial

  45. Feiba

    Takeda

    Hemophilia A With Inhibitor

    approved small molecule active

    1 trial

  46. Ferric carboxymaltose

    Takeda

    Cardiac Failure

    approved small molecule active

    1 trial

  47. Fruquintinib

    Takeda

    Colorectal Cancer

    approved small molecule active

    1 trial

  48. Guanfacine hydrochloride (TAK-503)

    Takeda

    Attention Deficit Hyperactivity Disorder

    approved small molecule completed

    1 trial

Frequently asked questions

How many clinical projects does Takeda have?

1,179 published programs are linked to this sponsor in our ClinicalTrials.gov index.

Is this the complete company pipeline?

This directory lists published programs for the sponsor in our database. Partnered or out-licensed assets may appear under multiple companies.

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.